Skip to main content
Erschienen in: Cancer Causes & Control 4/2007

01.05.2007 | Original Paper

Descriptive study of gallbladder, extrahepatic bile duct, and ampullary cancers in the United States, 1997–2002

verfasst von: M. T. Goodman, Jennifer Yamamoto

Erschienen in: Cancer Causes & Control | Ausgabe 4/2007

Einloggen, um Zugang zu erhalten

Abstract

Objective

Few investigations of biliary tract (gallbladder, extrahepatic bile duct, ampulla of Vater) cancers have been conducted because of the relative rarity of these malignancies. The objective of this analysis was to compare the demographic, pathological, and clinical features of biliary tract cancers among men and women.

Methods

Biliary tract cancers among 11,261 men and 15,722 women were identified through 33 US population-based registries during the period 1997–2002. These registries were estimated to represent 61% of the US population. Age-adjusted incidence rates (AAIR) were calculated per 100,000 population using counts derived from the 2000 US census.

Results

The AAIR for gallbladder cancer among men (0.82 per 100,000) was significantly lower than the AAIR among women (1.45 per 100,000). By contrast, rates for extrahepatic bile duct and ampullary cancers were significantly higher among men (0.93 per 100,000 and 0.70 per 100,000, respectively) than among women (0.61 per 100,000 and 0.45 per 100,000, respectively). White men and women had significantly lower AAIRs for gallbladder cancer compared with other racial-ethnic groups, with the highest rates among Hispanics, American Indian-Alaska Natives, and Asian-Pacific Islanders. Asian-Pacific Islanders and Hispanics of both sexes had the highest AAIRs for extrahepatic bile duct and ampullary cancers. Ampullary tumors were more likely to be diagnosed at a localized or regional stage than were cancers of the gallbladder and extrahepatic bile duct. Asian-Pacific Islander men and women tended to have more unstaged cancers than other groups.

Conclusions

This population-based study suggests distinct etiologies of anatomic subsites of biliary tract cancer and caution against analytic investigations of all biliary tract cancers combined.
Literatur
1.
Zurück zum Zitat Khan ZR, Neugat AI, Ahasan H, Chabot JA (1999) Risk factors for biliary tract cancers. Am J Gastroenterol 94:149–152PubMedCrossRef Khan ZR, Neugat AI, Ahasan H, Chabot JA (1999) Risk factors for biliary tract cancers. Am J Gastroenterol 94:149–152PubMedCrossRef
2.
Zurück zum Zitat Chow W-H, McLaughlin JK, Menck HR, Mack TM (1994) Risk factors for extrahepatic bile duct cancers: Los Angeles County, California (USA). Cancer Cause Control 5:267–272CrossRef Chow W-H, McLaughlin JK, Menck HR, Mack TM (1994) Risk factors for extrahepatic bile duct cancers: Los Angeles County, California (USA). Cancer Cause Control 5:267–272CrossRef
3.
Zurück zum Zitat Lowenfels AB, Maisonneuve P, Boyle P, Zatonski WA (1999) Epidemiology of gallbladder cancer. Hepatogastroenterology 46:1529–1532PubMed Lowenfels AB, Maisonneuve P, Boyle P, Zatonski WA (1999) Epidemiology of gallbladder cancer. Hepatogastroenterology 46:1529–1532PubMed
4.
Zurück zum Zitat Misra S, Chaturvedi A, Misra NC, Sharma ID (2003) Carcinoma of the gallbladder. Lancet Oncol 4:167–176PubMedCrossRef Misra S, Chaturvedi A, Misra NC, Sharma ID (2003) Carcinoma of the gallbladder. Lancet Oncol 4:167–176PubMedCrossRef
5.
Zurück zum Zitat Lazcano-Ponce EC, Miqual JF, Munoz N, et al (2001) Epidemiology and molecular pathology of gallbladder cancer. Ca Cancer J Clin 51:349–364PubMedCrossRef Lazcano-Ponce EC, Miqual JF, Munoz N, et al (2001) Epidemiology and molecular pathology of gallbladder cancer. Ca Cancer J Clin 51:349–364PubMedCrossRef
6.
Zurück zum Zitat Ekbom A, Hsieh CC, Yuen J, Trichopoulos D, McLaughlin JK, et al (1993) Risk of extrahepatic bile duct cancer after cholecystectomy. Lancet 342:1262–1265PubMedCrossRef Ekbom A, Hsieh CC, Yuen J, Trichopoulos D, McLaughlin JK, et al (1993) Risk of extrahepatic bile duct cancer after cholecystectomy. Lancet 342:1262–1265PubMedCrossRef
7.
Zurück zum Zitat Yeh S, Hsieh CC, MacMahon B (1987) Extrahepatic bile duct cancer and smoking, beverage consumption, past medical history, and oral contraceptive pill use. Cancer 59:2112–2116CrossRef Yeh S, Hsieh CC, MacMahon B (1987) Extrahepatic bile duct cancer and smoking, beverage consumption, past medical history, and oral contraceptive pill use. Cancer 59:2112–2116CrossRef
8.
Zurück zum Zitat Zhang XH, Andreotti G, Gao YT, Deng J, Liu E, Rashid A, Wu K, Sun L, Sakoda LC, Cheng JR, Shen MC, Wang BS, Han TQ, Zhang BH, Gridley G, Fraumeni JF Jr, Hsing AW (2006) Tea drinking and the risk of biliary tract cancers and biliary stones: a population-based case-control study in Shanghai, China. Int J Cancer 118:3089–3094PubMedCrossRef Zhang XH, Andreotti G, Gao YT, Deng J, Liu E, Rashid A, Wu K, Sun L, Sakoda LC, Cheng JR, Shen MC, Wang BS, Han TQ, Zhang BH, Gridley G, Fraumeni JF Jr, Hsing AW (2006) Tea drinking and the risk of biliary tract cancers and biliary stones: a population-based case-control study in Shanghai, China. Int J Cancer 118:3089–3094PubMedCrossRef
9.
Zurück zum Zitat Bergquist A, Ekbom A, Olsson R, Kornfeldt D, Loof L, Danielsson A, Hultcrantz R, Lindgren S, Prytz H, Sandberg-Gertzen H, Almer S, Granath F, Broome U (2002) Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 36:321–327PubMedCrossRef Bergquist A, Ekbom A, Olsson R, Kornfeldt D, Loof L, Danielsson A, Hultcrantz R, Lindgren S, Prytz H, Sandberg-Gertzen H, Almer S, Granath F, Broome U (2002) Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 36:321–327PubMedCrossRef
10.
Zurück zum Zitat Sakoda LC, Gao YT, Chen BE, Chen J, Rosenberg PS, Rashid A, Deng J, Shen MC, Wang BS, Han TQ, Zhang BH, Cohen-Webb H, Yeager M, Welch R, Chanock S, Fraumeni JF Jr, Hsing AW. (2006) Prostaglandin-endoperoxide synthase 2 (PTGS2) gene polymorphisms and risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China. Carcinogenesis 27:1251–1256PubMedCrossRef Sakoda LC, Gao YT, Chen BE, Chen J, Rosenberg PS, Rashid A, Deng J, Shen MC, Wang BS, Han TQ, Zhang BH, Cohen-Webb H, Yeager M, Welch R, Chanock S, Fraumeni JF Jr, Hsing AW. (2006) Prostaglandin-endoperoxide synthase 2 (PTGS2) gene polymorphisms and risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China. Carcinogenesis 27:1251–1256PubMedCrossRef
11.
Zurück zum Zitat Gonzalez-Perez A, Garcia Rodriguez LA, Lopez-Ridaura R (2003) Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis BMC. Cancer 3:28PubMed Gonzalez-Perez A, Garcia Rodriguez LA, Lopez-Ridaura R (2003) Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis BMC. Cancer 3:28PubMed
12.
Zurück zum Zitat Parkin DM, Whelan Sl, Ferlay J, et al (eds) (1997) Cancer incidence in five continents, volume VII. Lyon: International Agency for Research on Cancer. IARC Sci. Pubs. No. 143 Parkin DM, Whelan Sl, Ferlay J, et al (eds) (1997) Cancer incidence in five continents, volume VII. Lyon: International Agency for Research on Cancer. IARC Sci. Pubs. No. 143
13.
Zurück zum Zitat Everhart JE (2001) Gallstones and ethnicity in the Americas. J Assoc Acad Minor Phys 12:137–143PubMed Everhart JE (2001) Gallstones and ethnicity in the Americas. J Assoc Acad Minor Phys 12:137–143PubMed
14.
Zurück zum Zitat Black WC, Key CR, Carmany TB, Herman D (1977) Carcinoma of the gallbladder in a population of Southwestern American Indians. Cancer 39:1267–1279PubMedCrossRef Black WC, Key CR, Carmany TB, Herman D (1977) Carcinoma of the gallbladder in a population of Southwestern American Indians. Cancer 39:1267–1279PubMedCrossRef
15.
Zurück zum Zitat US Cancer Statistics Working Group. United States Cancer Statistics: 2001 Incidence and Mortality. Atlanta (GA): DHHS, CDC and NCI, 2004 US Cancer Statistics Working Group. United States Cancer Statistics: 2001 Incidence and Mortality. Atlanta (GA): DHHS, CDC and NCI, 2004
16.
Zurück zum Zitat Howe HL, Chen VW, Hotes J, Wu XC, Correa C, Fulton JP (eds) (2001) Cancer Incidence in North America 1994–1998, Volume One: Incidence. Springfield, IL. North American Association of Central Cancer Registries Howe HL, Chen VW, Hotes J, Wu XC, Correa C, Fulton JP (eds) (2001) Cancer Incidence in North America 1994–1998, Volume One: Incidence. Springfield, IL. North American Association of Central Cancer Registries
17.
Zurück zum Zitat NAACCR. Report of the NAACCR Expert Panel on Hispanic Identification 2003. North American Association of Central Cancer Registries: Springfield, IL. Also available from URL http://www.naaccr.org, 2004 NAACCR. Report of the NAACCR Expert Panel on Hispanic Identification 2003. North American Association of Central Cancer Registries: Springfield, IL. Also available from URL http://​www.​naaccr.​org, 2004
18.
Zurück zum Zitat Fritz A, Percy C, Jack A, et al (2000) International Classification of Disease for Oncology. 3rd edition. World Health Organization, Geneva Fritz A, Percy C, Jack A, et al (2000) International Classification of Disease for Oncology. 3rd edition. World Health Organization, Geneva
19.
Zurück zum Zitat Young J, Roffers S, Ries L, Fritz A, Hurlburt AE (eds) (2001) SEER Summary Staging Manual, 2000. Codes and Coding Instructions. Bethesda, MD: National Institutes of Health, National Cancer Institute Young J, Roffers S, Ries L, Fritz A, Hurlburt AE (eds) (2001) SEER Summary Staging Manual, 2000. Codes and Coding Instructions. Bethesda, MD: National Institutes of Health, National Cancer Institute
22.
Zurück zum Zitat Levi F, Lucchini F, Negri E, La Vecchia C (2003) The recent decline in gallbladder cancer mortality in Europe. Eur J Cancer Prev 12:265–267PubMedCrossRef Levi F, Lucchini F, Negri E, La Vecchia C (2003) The recent decline in gallbladder cancer mortality in Europe. Eur J Cancer Prev 12:265–267PubMedCrossRef
23.
Zurück zum Zitat Wood R, Fraser LA, Brewster DH, Garden OJ (2003) Epidemiology of gallbladder cancer and trends in cholecystectomy rates in Scotland, 1968–1998. Eur J Cancer 39:2080–2086PubMedCrossRef Wood R, Fraser LA, Brewster DH, Garden OJ (2003) Epidemiology of gallbladder cancer and trends in cholecystectomy rates in Scotland, 1968–1998. Eur J Cancer 39:2080–2086PubMedCrossRef
24.
Zurück zum Zitat Randi G, Franceschi S, La Vecchia C (2006) Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 118:1591–1602PubMedCrossRef Randi G, Franceschi S, La Vecchia C (2006) Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 118:1591–1602PubMedCrossRef
25.
Zurück zum Zitat Barakat J, Dunkelberg JC, Ma TY (2006) Changing patterns of gallbladder carcinoma in New Mexico. Cancer 106:434–440PubMedCrossRef Barakat J, Dunkelberg JC, Ma TY (2006) Changing patterns of gallbladder carcinoma in New Mexico. Cancer 106:434–440PubMedCrossRef
26.
Zurück zum Zitat Das A, Neugut AI, Cooper GS, Chak A (2004) Association of ampullary and colorectal malignancies. Cancer 100:524–530PubMedCrossRef Das A, Neugut AI, Cooper GS, Chak A (2004) Association of ampullary and colorectal malignancies. Cancer 100:524–530PubMedCrossRef
27.
Zurück zum Zitat Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Eisner MP, Horner MJ, Howlader N, Hayat M, Hankey BF, Edwards BK (eds) (2006) SEER Cancer Statistics Review, 1975–2003, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2003/, based on November 2005 SEER data submission, posted to the SEER web site Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Eisner MP, Horner MJ, Howlader N, Hayat M, Hankey BF, Edwards BK (eds) (2006) SEER Cancer Statistics Review, 1975–2003, National Cancer Institute. Bethesda, MD, http://​seer.​cancer.​gov/​csr/​1975_​2003/​, based on November 2005 SEER data submission, posted to the SEER web site
28.
Zurück zum Zitat Hsing AW, Gao YT, Devesa SS, Jin F, Fraumeni JF Jr (1998) Rising incidence of biliary tract cancers in Shanghai, China. Int J Cancer 75:368–370PubMedCrossRef Hsing AW, Gao YT, Devesa SS, Jin F, Fraumeni JF Jr (1998) Rising incidence of biliary tract cancers in Shanghai, China. Int J Cancer 75:368–370PubMedCrossRef
30.
Zurück zum Zitat Chow WH, Johansen C, Gridley G, Mellemkjaer L, Olsen JH, Fraumeni JF Jr (1999) Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas. Br J Cancer 79:640–644PubMedCrossRef Chow WH, Johansen C, Gridley G, Mellemkjaer L, Olsen JH, Fraumeni JF Jr (1999) Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas. Br J Cancer 79:640–644PubMedCrossRef
31.
Zurück zum Zitat O’Malley C, Hu KU, West DW. North American Association of Central Cancer Registries: race and ethnicity identifier assessment project (2002). Also available from URL http://www.naaccr.org O’Malley C, Hu KU, West DW. North American Association of Central Cancer Registries: race and ethnicity identifier assessment project (2002). Also available from URL http://​www.​naaccr.​org
32.
Zurück zum Zitat Kolonel LN, Goodman MT (1992) Racial variation in cancer: fact or artifact?. J Natl Cancer Inst 84:916–917CrossRef Kolonel LN, Goodman MT (1992) Racial variation in cancer: fact or artifact?. J Natl Cancer Inst 84:916–917CrossRef
Metadaten
Titel
Descriptive study of gallbladder, extrahepatic bile duct, and ampullary cancers in the United States, 1997–2002
verfasst von
M. T. Goodman
Jennifer Yamamoto
Publikationsdatum
01.05.2007
Verlag
Kluwer Academic Publishers
Erschienen in
Cancer Causes & Control / Ausgabe 4/2007
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-006-0109-4

Weitere Artikel der Ausgabe 4/2007

Cancer Causes & Control 4/2007 Zur Ausgabe

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.